These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35846341)

  • 1. Biomarkers for Detecting Kidney Dysfunction in Type-2 Diabetics and Diabetic Nephropathy Subjects: A Case-Control Study to Identify Potential Biomarkers of DN to Stratify Risk of Progression in T2D Patients.
    Harkin C; Cobice D; Brockbank S; Bolton S; Johnston F; Strzelecka A; Watt J; Kurth MJ; Lamont JV; Fitzgerald P; Moore T; Ruddock MW
    Front Endocrinol (Lausanne); 2022; 13():887237. PubMed ID: 35846341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential Role of N-Cadherin in Diagnosis and Prognosis of Diabetic Nephropathy.
    Ali H; Abu-Farha M; Hammad MM; Devarajan S; Bahbahani Y; Al-Khairi I; Cherian P; Alsairafi Z; Vijayan V; Al-Mulla F; Attar AA; Abubaker J
    Front Endocrinol (Lausanne); 2022; 13():882700. PubMed ID: 35712247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of the intrarenal arterial resistivity indices and different renal biomarkers for early identification of diabetic nephropathy in type 1 diabetic patients.
    Abd El Dayem S; El Bohy Ael M; El Shehaby A
    J Pediatr Endocrinol Metab; 2016 Mar; 29(3):273-9. PubMed ID: 26677884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological characteristics of non-diabetic renal disease in patients with type 2 diabetes mellitus in a northeastern Chinese medical center: a retrospective analysis of 273 cases.
    Liu S; Guo Q; Han H; Cui P; Liu X; Miao L; Zou H; Sun G
    Int Urol Nephrol; 2016 Oct; 48(10):1691-8. PubMed ID: 27272256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Cyclophilin A and serum Cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes.
    Salem NA; El Helaly RM; Ali IM; Ebrahim HAA; Alayooti MM; El Domiaty HA; Aboelenin HM
    Pediatr Diabetes; 2020 Aug; 21(5):846-855. PubMed ID: 32304131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of serum miR-29a in the occurrence and progression of diabetic nephropathy: A cross-sectional study.
    Liu Q; Wang M; Xu T; Liang W; Yang F
    J Clin Lab Anal; 2022 Feb; 36(2):e24210. PubMed ID: 34964177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ALCAM a novel biomarker in patients with type 2 diabetes mellitus complicated with diabetic nephropathy.
    Sulaj A; Kopf S; Gröne E; Gröne HJ; Hoffmann S; Schleicher E; Häring HU; Schwenger V; Herzig S; Fleming T; Nawroth PP; von Bauer R
    J Diabetes Complications; 2017 Jun; 31(6):1058-1065. PubMed ID: 28325697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carnosinase concentration, activity, and CNDP1 genotype in patients with type 2 diabetes with and without nephropathy.
    Zhang S; Albrecht T; Rodriguez-Niño A; Qiu J; Schnuelle P; Peters V; Schmitt CP; van den Born J; Bakker SJL; Lammert A; Krämer BK; Yard BA; Hauske SJ
    Amino Acids; 2019 Apr; 51(4):611-617. PubMed ID: 30610469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tocotrienol-Rich Vitamin E from Palm Oil (Tocovid) and Its Effects in Diabetes and Diabetic Nephropathy: A Pilot Phase II Clinical Trial.
    Tan SMQ; Chiew Y; Ahmad B; Kadir KA
    Nutrients; 2018 Sep; 10(9):. PubMed ID: 30227659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Endothelial Cell Injury Marker Cd146 Correlates with Disease Severity and Predicts the Renal Outcomes in Patients with Diabetic Nephropathy.
    Fan Y; Fei Y; Zheng L; Wang J; Xiao W; Wen J; Xu Y; Wang Y; He L; Guan J; Wei J; He JC; Wang N
    Cell Physiol Biochem; 2018; 48(1):63-74. PubMed ID: 30001528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significance of glycated LDL in different stages of diabetic nephropathy.
    Siddiqui K; George TP; Nawaz SS; Yaslam M; Almogbel E; Al-Rubeaan K
    Diabetes Metab Syndr; 2019; 13(1):548-552. PubMed ID: 30641763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
    J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor and podocin predict nephropathy progression in type 2 diabetic patients through interaction with the autophagy influencer ULK-1.
    El-Shazly AAA; Sallam AM; El-Hefnawy MH; El-Mesallamy HO
    J Diabetes Complications; 2019 Feb; 33(2):128-133. PubMed ID: 30545560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of miR-31 in Diabetic Nephropathy and its Relationship with Inflammation.
    Rovira-Llopis S; Escribano-Lopez I; Diaz-Morales N; Iannantuoni F; Lopez-Domenech S; Andújar I; Jover A; Pantoja J; Pallardo LM; Bañuls C; Victor VM
    Cell Physiol Biochem; 2018; 50(3):1005-1014. PubMed ID: 30355913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary peptidomics in a rodent model of diabetic nephropathy highlights epidermal growth factor as a biomarker for renal deterioration in patients with type 2 diabetes.
    Betz BB; Jenks SJ; Cronshaw AD; Lamont DJ; Cairns C; Manning JR; Goddard J; Webb DJ; Mullins JJ; Hughes J; McLachlan S; Strachan MWJ; Price JF; Conway BR
    Kidney Int; 2016 May; 89(5):1125-1135. PubMed ID: 27083286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Fibroblast Growth Factors 21 and 23 as Biomarkers of Progression in Diabetic Nephropathy in Type 2 Diabetes with Normoalbuminuria.
    El-Saeed AM; El-Mohasseb GF
    Egypt J Immunol; 2017 Jun; 24(2):93-99. PubMed ID: 29528583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of sTNFR1 and BNP Levels with Diminished Estimated Glomerular Filtration Rate in Type 2 Diabetic Egyptian Patients.
    Mokhtar ER; M E; Hassan MA; Abou-ELHassan HA; Alanany MG; Hasuna MA
    Egypt J Immunol; 2018 Jan; 25(1):57-69. PubMed ID: 30242998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan.
    Chien HY; Chen CY; Chiu YH; Lin YC; Li WC
    Int J Med Sci; 2016; 13(6):457-65. PubMed ID: 27279796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated YAP causes renal damage of type 2 diabetic nephropathy.
    Ma R; Ren JM; Li P; Zhou YJ; Zhou MK; Hu Z; Xiao XY
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):755-763. PubMed ID: 30720184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.